SynthesisEuropean archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry2026
Effects of isotretinoin on bone dynamics in the craniomaxillofacial region: a systematic review of preclinical evidence.
Synthesis in European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis systematic review provides a critical evaluation, synthesis of the existing literature on isotretinoin's effects on craniomaxillofacial bone.
methodsFollowing the PRISMA guidelines and registered in PROSPERO, the review was conducted in August 2024 across various databases. Eligible in vivo studies were analysed for their assessment of isotretinoin's effects on craniomaxillofacial bone. Risk of bias was performed according to the Systematic Review Centre for Laboratory Animal Experimentation's RoB tool for animal studies.
resultsOut of 3670 studies, eight were eligible. Four studies revealed increased hyalinised areas in specific dental root regions amongst isotretinoin-treated groups, alongside significant differences in osteoblast and osteoclast counts, capillary formation, and new bone growth, indicating isotretinoin's impact on bone tissue. Two studies reported no significant disparities in trabecular bone structure but observed variations in collagen formation, root resorption, and bone resorption frequency. Studies on isotretinoin's effects on bone repair reveal contrasting outcomes: higher doses (7.5 mg/kg/day) enhanced bone formation in calvaria defects, whilst lower doses (1 mg/kg/day) slowed bone healing in a rabbit rhinoplasty model, showing reduced healing rates compared to controls.
conclusionsThe reviewed studies indicate that isotretinoin has dose-dependent effects on bone remodelling. Higher doses enhance bone formation and alveolar repair but increase root resorption and alter bone morphology, whilst lower doses slow bone healing. Some studies report no significant changes in bone volume or displacement but note improved gingival healing. These findings emphasise the need for further research to guide clinical decisions on isotretinoin's long-term impact on craniomaxillofacial bone health.
Indexed as
Identifiers
40924363What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.